Evommune (EVMN) Other Non Operating Income (2024 - 2026)

Evommune (EVMN) has 3 years of Other Non Operating Income data on file, last reported at $2.3 million in Q1 2026.

• Quarterly Other Non Operating Income rose 380.0% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (changed N/A YoY) and the FY2025 annual result came in at $12.2 million, up 280.69% from the prior year.
• Other Non Operating Income rose to $2.3 million in Q1 2026 per EVMN's latest filing, from $1.4 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $2.3 million in Q1 2026 and bottomed at $475000.0 in Q1 2025.
• The 3-year median for Other Non Operating Income is $790500.0 (2024), against an average of $1.1 million.
• The widest annual swing landed in 2025, when Other Non Operating Income soared 41.93%; it then soared 380.0% in 2026.
• Tracing EVMN's Other Non Operating Income over 3 years: stood at $728000.0 in 2024, then surged by 98.21% to $1.4 million in 2025, then surged by 58.0% to $2.3 million in 2026.
• Per Business Quant, the three latest EVMN Other Non Operating Income figures stand at $2.3 million (Q1 2026), $1.4 million (Q4 2025), and $853000.0 (Q3 2025).

Peer Comparison